Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sanquin Blood Supply Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9828
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, and various other institutes. The organization’s plasma derived products cater to various immunology disorders, and blood clotting disorders. Sanquin also conducts research to discover and develop new solutions for medical problems in the areas of transfusion medicine, hematology and immunology. It conducts research in collaboration with academic and research centers in the Netherlands and other countries. The organization has subsidiaries in Finland, Belgium, and the Netherlands. Sanquin is headquartered in Amsterdam, the Netherlands.

Sanquin Blood Supply Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Devices Deals, 2012 to YTD 2018 9
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Xenikos Raises USD30 Million in Series B Financing 11
Xenikos Raises Funds in Venture Financing 12
Xenikos Raises US$7 Million In Series A Financing 13
Partnerships 15
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 15
Licensing Agreements 16
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16
Immatics Biotech Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 18
Sanquin Blood Supply Foundation – Key Employees 19
Sanquin Blood Supply Foundation – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Devices Deals, 2012 to YTD 2018 9
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xenikos Raises USD30 Million in Series B Financing 11
Xenikos Raises Funds in Venture Financing 12
Xenikos Raises US$7 Million In Series A Financing 13
Sanquin Blood Supply Enters Into Partnership with Okklo Life Sciences 15
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 16
Immatics Biotech Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
Neon Therapeutics Enters into Licensing Agreement with Sanquin Blood Supply Foundation 18
Sanquin Blood Supply Foundation, Key Employees 19
Sanquin Blood Supply Foundation, Subsidiaries 20

List of Figures
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sanquin Blood Supply Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sanquin Blood Supply Foundation, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Taewoong Medical Co Ltd:企業の製品パイプライン分析2018
    Summary Taewoong Medical Co Ltd (Taewoong Medical) is a medical device company that develops and manufactures stents and other medical devices. The company offers products such as self-expandable metal stent, endoscopic RFA, endoscopic accessory, ureteral stent, airway stent, colonic stent, surgical …
  • BELLUS Health Inc (BLU):製薬・医療:M&Aディール及び事業提携情報
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …
  • Exco Resources Inc (XCOOQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, and production of onshore natural gas and oil assets. It provides services such as portfolio re …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research p …
  • LCH.Clearnet Group Limited:企業の戦略・SWOT・財務情報
    LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report Summary LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Portigon Ag
    Portigon Ag - Strategy, SWOT and Corporate Finance Report Summary Portigon Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Blaze Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blaze Bioscience Inc (Blaze) is a biotechnology company that offers guided cancer therapy solutions. The company develops tumor paint products and optide-based guided cancer therapeutics. It provides cancer surgery by development of real-time, high-resolution view of cancer cell technologies …
  • Fresenius Kidney Care-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Northern Ireland Electricity Networks Ltd:企業の戦略的SWOT分析
    Northern Ireland Electricity Networks Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • EnCana Corporation:戦略・SWOT・企業財務分析
    EnCana Corporation - Strategy, SWOT and Corporate Finance Report Summary EnCana Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kawasaki Heavy Industries, Ltd.:企業の戦略・SWOT・財務分析
    Kawasaki Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • HanAll Biopharma Co Ltd (009420):企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • Davide Campari-Milano SpA:企業の戦略・SWOT・財務情報
    Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Nampak Limited:企業の戦略・SWOT・財務情報
    Nampak Limited - Strategy, SWOT and Corporate Finance Report Summary Nampak Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nichirei Corp (2871):企業の財務・戦略的SWOT分析
    Nichirei Corp (2871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • AliveCor Inc:医療機器:M&Aディール及び事業提携情報
    Summary AliveCor Inc (AliveCor) is a heart rate measuring technology provider. The company offers kardia mobile and kardia application. It provides medical-grade EKG in just thirty seconds. AliveCor’s kardia offers easy to use, affordable, portable and trusted. The company track data over time and m …
  • Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic's for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that …
  • NBN Co Ltd:企業の戦略的SWOT分析
    NBN Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Den-Mat Holdings LLC:医療機器:M&Aディール及び事業提携情報
    Summary Den-Mat Holdings LLC (Den-Mat) is a medical device company that manufactures and develops dental and related products. The company’s products include consumables, small equipment, and a full-service dental laboratory. Its consumables comprise geristore, core paste, tenure, ultra-bond, plashm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆